These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC. Jin Y; Dong H; Xia L; Yang Y; Zhu Y; Shen Y; Zheng H; Yao C; Wang Y; Lu S J Thorac Oncol; 2019 Aug; 14(8):1378-1389. PubMed ID: 31026576 [TBL] [Abstract][Full Text] [Related]
10. Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers. Mao J; Wang D; Long J; Yang X; Lin J; Song Y; Xie F; Xun Z; Wang Y; Wang Y; Li Y; Sun H; Xue J; Song Y; Zuo B; Zhang J; Bian J; Zhang T; Yang X; Zhang L; Sang X; Zhao H J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34873013 [TBL] [Abstract][Full Text] [Related]
11. Adjunctive Probiotic Gao G; Ma T; Zhang T; Jin H; Li Y; Kwok LY; Zhang H; Sun Z Front Immunol; 2021; 12():772532. PubMed ID: 34970262 [TBL] [Abstract][Full Text] [Related]
12. The intimate relationship between gut microbiota and cancer immunotherapy. Elkrief A; Derosa L; Zitvogel L; Kroemer G; Routy B Gut Microbes; 2019; 10(3):424-428. PubMed ID: 30339501 [TBL] [Abstract][Full Text] [Related]
13. Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma. Zheng Y; Wang T; Tu X; Huang Y; Zhang H; Tan D; Jiang W; Cai S; Zhao P; Song R; Li P; Qin N; Fang W J Immunother Cancer; 2019 Jul; 7(1):193. PubMed ID: 31337439 [TBL] [Abstract][Full Text] [Related]
14. Microbiome modulates immunotherapy response in cutaneous squamous cell carcinoma. Voigt AY; Walter A; Young TH; Graham JP; Batista Bittencourt BM; de Mingo Pulido A; Prieto K; Tsai KY; Sundberg JP; Oh J Exp Dermatol; 2023 Oct; 32(10):1624-1632. PubMed ID: 37350109 [TBL] [Abstract][Full Text] [Related]
15. Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients. Zhang C; Wang J; Sun Z; Cao Y; Mu Z; Ji X Cancer Sci; 2021 Aug; 112(8):3005-3017. PubMed ID: 34028936 [TBL] [Abstract][Full Text] [Related]
16. Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial. Borgers JSW; Burgers FH; Terveer EM; van Leerdam ME; Korse CM; Kessels R; Flohil CC; Blank CU; Schumacher TN; van Dijk M; Henderickx JGE; Keller JJ; Verspaget HW; Kuijper EJ; Haanen JBAG BMC Cancer; 2022 Dec; 22(1):1366. PubMed ID: 36585700 [TBL] [Abstract][Full Text] [Related]
17. Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients. Peters BA; Wilson M; Moran U; Pavlick A; Izsak A; Wechter T; Weber JS; Osman I; Ahn J Genome Med; 2019 Oct; 11(1):61. PubMed ID: 31597568 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma. Limeta A; Ji B; Levin M; Gatto F; Nielsen J JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33268597 [TBL] [Abstract][Full Text] [Related]
19. Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response. Spencer CN; McQuade JL; Gopalakrishnan V; McCulloch JA; Vetizou M; Cogdill AP; Khan MAW; Zhang X; White MG; Peterson CB; Wong MC; Morad G; Rodgers T; Badger JH; Helmink BA; Andrews MC; Rodrigues RR; Morgun A; Kim YS; Roszik J; Hoffman KL; Zheng J; Zhou Y; Medik YB; Kahn LM; Johnson S; Hudgens CW; Wani K; Gaudreau PO; Harris AL; Jamal MA; Baruch EN; Perez-Guijarro E; Day CP; Merlino G; Pazdrak B; Lochmann BS; Szczepaniak-Sloane RA; Arora R; Anderson J; Zobniw CM; Posada E; Sirmans E; Simon J; Haydu LE; Burton EM; Wang L; Dang M; Clise-Dwyer K; Schneider S; Chapman T; Anang NAS; Duncan S; Toker J; Malke JC; Glitza IC; Amaria RN; Tawbi HA; Diab A; Wong MK; Patel SP; Woodman SE; Davies MA; Ross MI; Gershenwald JE; Lee JE; Hwu P; Jensen V; Samuels Y; Straussman R; Ajami NJ; Nelson KC; Nezi L; Petrosino JF; Futreal PA; Lazar AJ; Hu J; Jenq RR; Tetzlaff MT; Yan Y; Garrett WS; Huttenhower C; Sharma P; Watowich SS; Allison JP; Cohen L; Trinchieri G; Daniel CR; Wargo JA Science; 2021 Dec; 374(6575):1632-1640. PubMed ID: 34941392 [TBL] [Abstract][Full Text] [Related]
20. The gut microbiota and immune checkpoint inhibitors. Humphries A; Daud A Hum Vaccin Immunother; 2018; 14(9):2178-2182. PubMed ID: 29494275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]